Virios Therapeutics (VIRI) Stock Chart & Stock Price History $4.82 +0.13 (+2.77%) As of 07/23/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock Virios Therapeutics Stock Price Performance The Virios Therapeutics (VIRI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1,990.20%, with a year-to-date return of 69.12%. In the past month, the stock has increased 1.26%, reflecting recent market activity. As of the latest close, Virios Therapeutics traded at $4.69 with a market cap of $90.32 million and volume of 34,047 shares. Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.26%1 Month Performance+1.26%3 Month Performance-17.89%Year-To-Date Performance+69.12%1 Year Performance+1,990.20% VIRI Stock Chart for Thursday, July, 24, 2025 VIRI Chart by TradingView Virios Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$4.69$4.82+2.77%$4.82$4.6911,765 shs$92.82 million07/23/2025$4.83$4.69-2.90%$4.80$4.6034,047 shs$90.32 million07/22/2025$4.83$4.83$4.90$4.7516,126 shs$93.02 million07/21/2025$4.83$4.83$4.90$4.7516,126 shs$93.02 million07/18/2025$4.50$4.76+5.78%$4.90$4.5223,193 shs$91.67 million07/17/2025$4.70$4.50-4.26%$4.80$4.5047,170 shs$86.66 million07/16/2025$5.08$4.70-7.48%$5.12$4.6459,460 shs$90.51 million07/15/2025$4.76$5.08+6.72%$5.08$4.7331,482 shs$97.83 million07/14/2025$4.76$4.76$4.95$4.7131,531 shs$91.67 million07/11/2025$4.92$4.99+1.42%$5.09$4.9231,162 shs$96.10 million Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$4.84$4.92+1.65%$4.92$4.8035,955 shs$94.75 million07/09/2025$4.80$4.84+0.83%$4.89$4.7042,790 shs$93.21 million07/08/2025$4.80$4.80$4.88$4.7512,767 shs$92.44 million07/07/2025$4.80$4.80$4.88$4.7512,767 shs$92.44 million07/04/2025$4.83$4.80-0.62%$4.88$4.7512,767 shs$92.44 million07/03/2025$4.95$4.83-2.42%$5.00$4.8336,108 shs$93.02 million07/02/2025$4.77$4.95+3.77%$5.00$4.7525,682 shs$95.33 million07/01/2025$4.71$4.77+1.27%$4.87$4.714,575 shs$91.86 million06/30/2025$4.71$4.71$4.86$4.6614,969 shs$90.71 million06/27/2025$4.80$4.77-0.63%$4.82$4.7116,339 shs$91.86 million06/26/2025$4.85$4.80-1.03%$4.85$4.7212,609 shs$92.44 million06/25/2025$4.76$4.85+1.89%$4.90$4.7114,714 shs$93.40 million06/24/2025$4.90$4.76-2.86%$4.96$4.7513,455 shs$91.67 million06/23/2025$4.90$4.90$5.00$4.7146,549 shs$94.36 million Related Companies Arcturus Therapeutics Stock Price Chart Monte Rosa Therapeutics Stock Price Chart Humacyte Stock Price Chart CryoPort Stock Price Chart Inhibrx Biosciences Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Foghorn Therapeutics Stock Price Chart Candel Therapeutics Stock Price Chart Aura Biosciences Stock Price Chart Abeona Therapeutics Stock Price Chart Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRI) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virios Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
